Your browser doesn't support javascript.
loading
Blockade of TGF-ß signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models.
Newsted, Daniel; Banerjee, Sunandan; Watt, Kathleen; Nersesian, Sarah; Truesdell, Peter; Blazer, Levi L; Cardarelli, Lia; Adams, Jarrett J; Sidhu, Sachdev S; Craig, Andrew W.
Afiliação
  • Newsted D; Department of Biomedical and Molecular Sciences, Queen's University; Cancer Biology & Genetics division, Queen's Cancer Research Institute, Kingston, ON, Canada.
  • Banerjee S; The Donnelly Centre, University of Toronto, Toronto, ON, Canada.
  • Watt K; Department of Biomedical and Molecular Sciences, Queen's University; Cancer Biology & Genetics division, Queen's Cancer Research Institute, Kingston, ON, Canada.
  • Nersesian S; Department of Biomedical and Molecular Sciences, Queen's University; Cancer Biology & Genetics division, Queen's Cancer Research Institute, Kingston, ON, Canada.
  • Truesdell P; Department of Biomedical and Molecular Sciences, Queen's University; Cancer Biology & Genetics division, Queen's Cancer Research Institute, Kingston, ON, Canada.
  • Blazer LL; The Donnelly Centre, University of Toronto, Toronto, ON, Canada.
  • Cardarelli L; The Donnelly Centre, University of Toronto, Toronto, ON, Canada.
  • Adams JJ; The Donnelly Centre, University of Toronto, Toronto, ON, Canada.
  • Sidhu SS; The Donnelly Centre, University of Toronto, Toronto, ON, Canada.
  • Craig AW; Department of Biomedical and Molecular Sciences, Queen's University; Cancer Biology & Genetics division, Queen's Cancer Research Institute, Kingston, ON, Canada.
Oncoimmunology ; 8(2): e1539613, 2019.
Article em En | MEDLINE | ID: mdl-30713798

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article